Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump 
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Sony Forecasts Lower 2027 Profit Despite Strong Music and Sensor Growth 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping 
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
MEDFORD, N.Y., April 26, 2018 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for the first quarter 2018 after the close of trading on Wednesday, May 9, 2018. The Company’s management team will host a corresponding conference call beginning at 4:30 pm ET.
Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at www.chembio.com. A telephone replay will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US using passcode 28132 until 4:30pm ET on Wednesday, May 16, 2018.
Contact:
Lynn Pieper Lewis
Gilmartin Group
Investor Relations
(415) 937-5402
[email protected]
